Fluvirin®

also known as TIV

Developed for: influenza
Investigated by: Novartis Vaccines · Novartis Vaccines and Diagnostics (formerly Chiron Vaccines)

today NCT00264576 · Ph 2

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT00264576	Oct → Dec 2005	influenza	Novartis Vaccines	Completed	Mixed

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Fluvirin	“US-licensed Trivalent Inactivated Influenza Vaccine (Fluvirin®) Produced in Embryonated Hen Eggs” NCT00264576 ↗
Known as	TIV	“an injectable egg-based trivalent inactivated influenza vaccine (TIV)” PMID 19673652 ↗ Sep 2009
Modality	Vaccine	“an injectable egg-based trivalent inactivated influenza vaccine (TIV)” PMID 19673652 ↗ Sep 2009